Fed. Circ. Backs Melinta Patent Win In Injections Case
Nexus Pharmaceuticals lost its appeal of an Illinois federal judge's finding that it infringed a pair of patents relating to a line of injections that treat infections, after the Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article